Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Emmaus Life Sciences
AddedFeb 19, 2024
UpdatedJun 18, 2026
Emmaus Life Sciences

Emmaus Life Sciences

Public

Emmaus Life Sciences, a CA-based medical firm, develops treatments for rare diseases like sickle cell.

HQ
Torrance, CA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Emmaus Life Sciences is engaged in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases. Their focus has been on rare and orphan diseases, such as sickle cell disease.

Their product candidate is an oral pharmaceutical grade L-glutamine treatment that demonstrated positive clinical results in their completed phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.

Emmaus Life Sciences - Similar Companies

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Empire Biotechnologies logo

Empire Biotechnologies

Orphan Star Therapeutics logo

Orphan Star Therapeutics

Edimer Pharmaceuticals logo

Edimer Pharmaceuticals

Eumentis Therapeutics logo

Eumentis Therapeutics

Emerald Health Pharmaceuticals logo

Emerald Health Pharmaceuticals

Phoenicis logo

Phoenicis

Kezar Life Sciences logo

Kezar Life Sciences

Orbus Therapeutics logo

Orbus Therapeutics

Amicus Therapeutics logo

Amicus Therapeutics

amicusrx.com

Glycomine logo

Glycomine

glycomine.com

Embera Neurotherapeutics logo

Embera Neurotherapeutics

emberaneuro.com

Harmony Biosciences logo

Harmony Biosciences

Wave Life Sciences logo

Wave Life Sciences

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Emmaus Life Sciences - Quick Facts

Who are Emmaus Life Sciences' competitors?

Companies similar to Emmaus Life Sciences include Lumos Pharma, Empire Biotechnologies, Orphan Star Therapeutics and Edimer Pharmaceuticals.

When was Emmaus Life Sciences founded?

Emmaus Life Sciences was founded in 2000.

Where is Emmaus Life Sciences' headquarters located?

Emmaus Life Sciences' headquarters is located in Torrance, CA, US.

When was Emmaus Life Sciences' last funding round?

Emmaus Life Sciences' most recent funding round was for $110k (USD) in June 2022.

How much has Emmaus Life Sciences raised to-date?

As of Jun 30, 2022, Emmaus Life Sciences has raised a total of $110k (USD).

How many employees does Emmaus Life Sciences have?

Emmaus Life Sciences has 55 employees as of Feb 6, 2024.

Emmaus Life Sciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Pharmaceutical
Unique IDs
  • ein: 870419387
  • secCik: 0000822370
  • ticker: EMMA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 25 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325600Soap, Cleaning Compound, and Toilet Preparation Manufacturing
  • 325610Soap and Cleaning Compound Manufacturing
  • 325611Soap and Other Detergent Manufacturing
  • 325620Toilet Preparation Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2844Perfumes, Cosmetics, And Other Toilet Preparations
  • 8090Miscellaneous Health And Allied Services, Not Elsewhere Classified
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6000Depository Institutions
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2023Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations
  • 7210Research and experimental development on natural sciences and engineering